A carregar...
The Patient Journey with PCSK9 Inhibitors in Community Practice
BACKGROUND: Trials have demonstrated that proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are effective as an adjunct to statin therapy, but access and cost issues have limited their use in community practice. OBJECTIVE: To better understand patients’ experiences when trying to obta...
Na minha lista:
| Publicado no: | J Clin Lipidol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7376543/ https://ncbi.nlm.nih.gov/pubmed/31371271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacl.2019.06.008 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|